Nisa Investment Advisors
RUBY

Nisa Investment Advisors’s Rubius Therapeutics, Inc RUBY Stock Holding History

Nisa Investment Advisors’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-41,900
Closed -$231K – 2549
2022
Q1 		$231K Buy
41,900
+41,100
+5,138% +$261K ﹤0.01% 1326
2021
Q4 		$5K Hold
800
– – ﹤0.01% 2101
2021
Q3 		$14 Sell
800
-65,000
-99% -$1.41M ﹤0.01% 2165
2021
Q2 		$1.61K Buy
+65,800
New +$1.65M 0.01% 783
2020
Q4 		– Sell
-480
Closed -$2K – 2384
2020
Q3 		$2K Hold
480
– – ﹤0.01% 2237
2020
Q2 		$3K Hold
480
– – ﹤0.01% 2045
2020
Q1 		$2K Buy
+480
New +$3.56K ﹤0.01% 2053

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nisa Investment Advisors's RUBY Position: Q2 2022 in Review

Nisa Investment Advisors sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 41,900 shares — an estimated $231K sold.

Nisa Investment Advisors first reported a position in RUBY in Q1 2020 and held it in 7 quarters. The position peaked at $231K in Q1 2022. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Nisa Investment Advisors reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 41,900 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $231K.
  • Nisa Investment Advisors first reported a position in Rubius Therapeutics, Inc in Q1 2020 and held it in 7 quarters.
  • Nisa Investment Advisors's Rubius Therapeutics, Inc position peaked at $231K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Nisa Investment Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.